ENG
History
2021
- 12
- Permission for Manufacturing Advanced Biological Products
- 09
- Strategic investment(20 million USD)
- 06
-
Completion of GMP facility
Series B financing(48 million USD)
- 05
- MOU with Ewha University Medical Center
- 01
-
MOU with International Vaccine Institute(IVI)
MOU with Severance hospital
MOU with GI-BIOME
2020
- 12
- Awardee of ‘Cytiva Korea CEO award’ at the 2020 Bio Challenge
- 10
- Success in Scale-up to 50L of T.O.P. NK
- 07
- Research Collaboration with Miltenyi Biotec Inc.
- 06
- Series A financing(26 million USD)
- 04
- Nano NK research on the cover of Advanced Material Journal (IF=30.85)
2019
- 07
- Non-exclusive agreement of GI-101
- 05
- Registration of our affiliate R&D center
- 02
- Accreditation as a bio-venture
- 01
- In-licensing of Nano NK cell
2018
- 10
-
In-licensing for Drone Treg cell
Foundation of GI-Cell
